Northwest Biotherapeutics reported -91666000 in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agenus AGEN:US $ 3.42M 12.3M
Applied Genetic Technologies AGTC:US $ 29.48M 17.55M
AstraZeneca AZN:LN 2951310.75M 184237.79M
Bristol Myers Squibb BMY:US $ 32600M 1020M
Celldex Therapeutics CLDX:US $ 365.09M 33.01M
Cti Biopharma CTIC:US $ -5.27M 22.64M
Cytori Therapeutics CYTX:US $ 9.68M 4.96M
Cytrx CYTR:US 3.28M 1.5M
Eisai 4523:JP Y 804545M 55723M
Genocea Biosciences GNCA:US $ 12.38M 14.69M
Infinity Pharmaceuticals INFI:US $ -1.11M 11.09M
Northwest Biotherapeutics NWBO:US -91666000 28.86M